The Texas Racing Commission has authorized the Texas Medical Diagnostic Laboratory to increase the amount of ELISA tests it conducts and decrease the number of screens it evaluates from urine samples collected for post-race analysis.
The Kentucky Equine Drug Research Council met Thursday at Keeneland to discuss options to identify and enforce the prohibited use of erythropoietin (EPO).
The attached list of racing organizations and officials were invited to attend a one-day workshop for the purpose of determining if agreement could be reached as to the need for a uniform policy for racehorse medication in the United States, and if so, where agreement can be reached on elements of such a policy. The workshop consisted of two segments: a two-hour open session briefing by experts on topics pertinent to the purpose of the Summit, and an intensive seven-hour workshop for the invited representatives which was conducted by a professional facilitator from outside the racing industry.
Most Popular Stories
- Bal a Bali Vying for U.S. Score in American
- Pletcher Considers Preakness Stakes Options
- Princess Violet Tops Ruffian Stakes Entrants
- KHRC Vote on Salix Threshold Triggers Debate
- Unspurned Seeks Repeat Performance in Hendrie
- Beholder, Warren's Veneda Face Off in Vanity
- Wolf Man Rocket Ships in for Peter Pan Stakes
- NYRA to Cap Belmont Attendance at 90,000
- MarketWatch: Jamie Hill on Sires, Pinhooking
- Hardest Core in Man o' War vs. Imagining